Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
[18F]fluoroestradiol (FES)
DRUG
2 trials
Sponsors
Asan Medical Center
Conditions
Carcinoma, Lobular
Recurrent Breast Cancer
Stage IV Breast Cancer
Phase 2
Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma
Completed
NCT05960201
Asan Medical Center
Carcinoma, Lobular
Start: 2023-08-10
End: 2024-08-20
Updated: 2024-08-21
Phase 3
Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Completed
NCT01986569
Asan Medical Center
Recurrent Breast Cancer, Stage IV Breast Cancer
Start: 2013-11-30
End: 2016-11-30
Updated: 2016-12-08
Related Papers
Diagnostic accuracy and safety of 16α-[<sup>18</sup>F]fluoro-17β-oestradiol PET-CT for the assessment of oestrogen receptor status in recurrent or metastatic lesions in patients with breast cancer: a prospective cohort study.
2019-03-04
79 citations